Magnus Financial Group’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-28,846
Closed -$1.36M 367
2020
Q4
$1.36M Hold
28,846
0.14% 58
2020
Q3
$1.34M Hold
28,846
0.16% 54
2020
Q2
$1.04M Hold
28,846
0.12% 69
2020
Q1
$1.02M Sell
28,846
-28,846
-50% -$1.18M 0.14% 73
2019
Q4
$2.62M Hold
57,692
0.38% 34
2019
Q3
$1.43M Hold
57,692
0.27% 48
2019
Q2
$1.27M Hold
57,692
0.24% 54
2019
Q1
$933K Buy
+57,692
New +$895K 0.19% 61

Other funds holding ZYME

Magnus Financial Group's ZYME Position: Q1 2021 in Review

Magnus Financial Group sold out of Zymeworks (ZYME) in Q1 2021, closing a stake of 28,846 shares — an estimated $1.36M sold.

Magnus Financial Group first reported a position in ZYME in Q1 2019 and held it in 8 quarters. The position peaked at $2.62M in Q4 2019. 125 funds tracked by Wall St. Rank hold ZYME as of Q1 2021.

  • Magnus Financial Group reported no remaining Zymeworks position as of Q1 2021 after selling out during the quarter.
  • Magnus Financial Group sold 28,846 Zymeworks shares in Q1 2021, an estimated $1.36M.
  • Magnus Financial Group first reported a position in Zymeworks in Q1 2019 and held it in 8 quarters.
  • Magnus Financial Group's Zymeworks position peaked at $2.62M in Q4 2019.
  • 125 funds tracked by Wall St. Rank held Zymeworks as of Q1 2021.

Based on Magnus Financial Group's 13F filing for Q1 2021, filed 5 May 2021.